Anbio Biotechnology (NASDAQ:NNNN) Stock Price Up 5.5% – Time to Buy?

Anbio Biotechnology (NASDAQ:NNNN) was up 5.5% during mid-day trading on Thursday. The stock traded as high as $3.86 and last traded at $3.9250. Approximately 6,260 shares were traded during mid-day trading, a decline of 92% from the average daily volume of 78,430 shares. The stock had previously closed at $3.72.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, October 8th. One equities research analyst has rated the stock with a Hold rating. According to MarketBeat, Anbio Biotechnology has an average rating of “Hold”.

Anbio Biotechnology Price Performance

The company has a 50-day simple moving average of $6.10 and a two-hundred day simple moving average of $15.11.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.